Gallium nitrate suppresses the production of nitric oxide and liver damage in a murine model of LPS-induced septic shock

Life Sciences

Volumn 65, Issue 13, 1999, Pages 1359-1371

  Krecic Shepard, Mary Ellen ^a,b   Shepard, Dale R ^a   Mullet, Daniel ^a   Apseloff, Glen ^a   Weisbrode, Steven E ^a   Gerber, Nicholas ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Gallium; Nitric oxide; Sepsis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GALLIUM NITRATE; GAMMA INTERFERON; NITRIC OXIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; LIVER HISTOLOGY; LIVER INJURY; MALE; NONHUMAN; SEPTIC SHOCK;

EID: 0033588541     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00375-6     Document Type: Article

References (43)

1. A. Zembowicz and J.R. Vane, Proc Natl Acad Sci USA 89 2051-2055 (1992).
2. R.C. Bone, C.J. Fisher Jr., T.P. Clemmer, G.J. Slotman, C.A. Metz and R.A. Balk, N Engl J Med 317 653-658 (1987).
3. C.J. Fisher Jr, J.F. Dhainaut, S.M. Opal, J.P. Pribble, R.A. Balk, G.J. Slotman, T.J. Iberti, E.C. Racknow, M.J. Shapiro, R.L. Greenman, et al., JAMA 271 1836-1843 (1994).
4. B.P. Giroir, Crit Care Med 21 780-786 (1993).
5. B. Beutler and V. Kruys, J Cardiovasc Pharmacol 25 Suppl 2 S1-S8 (1995).
6. X. Zhang and D.C. Morrison, J Exp Med 177 511-516 (1993).
7. J.-I. Nagakawa, I. Hishinuma, K. Miyamoto, M. Hirota, S. Abe, T. Yamanaka, K.-I. Katayama and I. Yamatsui, J Pharm Exp Ther 262 145-150 (1992).
8. Y. Tanaka, K. Kobayashi, A. Takahashi, I. Arai, S. Higuchi, S. Otomo, S. Habu, and T. Nishimura, J Immunol 151 5088-95 (1993).
9. J. Nagakawa, I. Hishinuma, K. Hirota, K. Miyamoto, T. Yamanaka, K. Tsukidate, K. Katayama and I. Yamatsu, Gastroenterology 99 758-765 (1990).
10. B. Beutler, New Horiz 1 3-12 (1993).
11. F.P. Heinzel, J Immunol 145 2920-2924 (1990).
12. T. Evans, A. Carpenter, H. Kinderman and J. Cohen, Circ Shock 41 77-81 (1993).
13. M.A. Marletta, P.S. Yoon, R. Iyengar, C.D. Leaf and J.S. Wishnok, Biochem 27 8706-8711 (1988).
14. R.D. Curran, T.R. Billiar, D.J. Stuehr, K. Hofmann and R.L. Simmons, J Exp Med 170 1769-1774 (1989).
15. M.W. Radomski, R.M. Palmer and S. Moncada, Proc Natl Acad Sci USA 87 10043-10047 (1990).
16. D.D. Rees, S. Cellek, R.M. Palmer and S. Moncada, Biochem Biophys Res Commun 173 541-547 (1990).
17. C. Thiemermann, Adv Pharmacol 28 45-79 (1994).
18. V. Matkovic, G. Apseloff, D.R. Shepard and N. Gerber, Lancet 335 72-75 (1990).
19. R.P. Warrell, Jr., R.S. Bockman, C.J. Coonley, M. Isaacs, H. Staszewski, J Clin Invest 73 1487-90 (1984).
20. C. Whitacre, G. Apseloff, K. Cox, V. Matkovic, S. Jewell and N. Gerber, J Neuroimmunol 39 175-182 (1992).
21. V. Matkovic, A. Balboa, D. Clinchot, C. Whitacre, B. Zwilling, D. Brown, S.E. Weisbrode, G. Apseloff and N. Gerber, Curr Ther Res 50 255-267 (1991).
22. G. Apseloff, K.V. Hackshaw, C. Whitacre, S.E. Weisbrode and N. Gerber, Naunyn-Schmiedberg's Arch Pharmacol 356 517-525 (1997).
23. M.C. Lobanoff, A.T. Kozhich, D.I. Mullet, N. Gerber, I. Gery, C.-C. Chan and S.M. Whitcup, Exp Eye Res 65 797-801 (1997).
24. C.G. Orosz, E. Wakely, S.D. Bergese, A.M. Vanbuskirk, R.M. Ferguson, D.I. Mullet, G. Apseloff and N. Gerber, Transplantation 61 783-791 (1996).
25. E. Maurel, A.M. Mazard and H. Bouissou, Pathol Biol 24 349-354 (1976).
26. W.R. Drobyski, R. Ul-Haq, D. Majewski and C.R. Chitambar, Blood 88 3056-3064 (1996).
27. E.H. Huang, D.M. Gabler, M.E. Krecic, N. Gerber, R.M. Ferguson and C.G. Orosz, Transplantation 58 1216-1222 (1994).
28. H. Okamura, K. Kawaguchi, K. Shoji and Y. Kawade, Infect Immun 38 440-443 (1982).
29. H.H. Schmidt, Biochemica 2 22, (1995).
30. B. Beutler and C. Van Huffel, Ann N Y Acad Sci 730 118-133 (1994).
31. C. Thiemermann, C.C. Wu, C. Szabo, M. Perretti and J.R. Vane, Br J Pharmacol 110 177-182 (1993).
32. T. Calandra, J.D. Baumgartner, G.E. Grau, M.M. Wu, P.H. Lambert, J. Schellekens, J. Verhoef, M.P. Glauser and the Swiss-Dutch J5 Immunoglobulin Study Group, J Infect Dis 161 982-987 (1990).
33. J. Wayte, A.T. Silva, T. Krausz and J. Cohen, Crit Care Med 21 1207-1212 (1993).
34. K.J. Tracey, Y. Fong, D.G: Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, S.F. Lowry and A. Cerami, Nature 330 662-664 (1987).
35. C.J.J. Fisher Jr, J.M. Agosti, S.M. Opal, S.F. Lowry, R.A. Balk, J.C. Sadoff, E. Abraham, R.M. Schein and E. Benjamin, N Engl J Med 334 1697-1702 (1996).
36. Q. Wang, J. Jacobs, J. Deleo, H. Kruszyna, R. Kruszyna, R. Smith and D. Wilcox, Life Sci 49 PL-55-PL-60 (1991).
37. N. Makkonen, M.R. Hirvonen, K. Savolainen, S. Lapinjoki and J. Monkkonen, Inflamm Res 44 523-528 (1995).
38. A. Morikawa, Y. Kato, T. Sugiyama, N. Koide, D. Chakravortty, T. Yoshida, T. Yokochi, Infect Immun 67 1018-24 (1999).
39. G.M. Wray, C.G. Miller, C.J. Hinds, C. Thiemermann, Shock 9 329-335 (1998).
40. B. Tunctan, O. Uludag, S. Altug, N. Abacioglu, Pharmacol Res 38 405-411 (1998).
41. C.A. Dinarello, Curr Top Microbiol Immunol 216 133-165 (1996).
42. S. Okusawa, J.A. Gelfand, T. Ikejima, R.J. Connolly and C.A. Dinarello, J Clin Invest 81 1162-1172 (1988).
43. K. Ohlsson, P. Bjork, M. Bergenfeldt, R. Hageman and R.C. Thompson, Nature 348 550-552 (1990).